We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biologics Stakeholders Seek Clearer Guidance on Post-Approval Changes
Biologics Stakeholders Seek Clearer Guidance on Post-Approval Changes
The FDA’s draft guidance on post-approval manufacturing changes for biological products needs work to clarify how it fits with previous agency documents, according to written comments on the draft.